A research study in Bosnia and Herzegovina to test an intervention called DIALOG+, designed to improve care for people living in the community with severe mental illness

Testing the effectiveness, acceptability and feasibility of DIALOG+ in severe mental illness in Bosnia and Herzegovina: a randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13347129

Enrollment

Registered

2018-11-20

Start date

2018-12-01

Completion date

Unknown

Last updated

2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with a diagnosis of severe mental illness: includes diagnoses of severe depression and anxiety Mental and Behavioural Disorders

Interventions

14 clinicians will be recruited. For each clinician, the research team will recruit 5-6 of their patients and then each clinician-patient cluster will be randomly allocated to a control or interventio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of severe mental illness (ICD-10 F3 or F4) 2. Attending the outpatient clinic or day hospital at Clinical Center University of Sarajevo 3. Aged 18 years or older 4. Capacity to provide informed consent 5. Scores 5 or below on the MANSA scale 6. Illness of over 6 months

Exclusion criteria

Exclusion criteria: 1. Does not meet inclusion criteria 2. Primary diagnosis of substance-use disorder, learning disability, dementia, organic psychosis 3. Diagnosis of bipolar disorder 4. An inpatient at the time of recruitment 5. Participating in another study conducted by this or another research group

Design outcomes

Primary

Measure	Time frame
Quality of life, measured using the Manchester Short Assessment of Quality of Life (MANSA), collected by masked researchers using a case report form as part of a research assessment at baseline, 6 months and 12 months	—

Secondary

Measure	Time frame
1. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months 2. Objective social functioning, measured using the Objective social outcome index (SIX) at baseline, 6 and 12 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months 4. Therapeutic relationship in community mental health care, measured using STAR-P at baseline, 6 and 12 months 5. Client satisfaction, measured using client satisfaction questionnaire (CSQ-8) at 6 and 12 months 6. Symptoms, measured using Hospital Anxiety and Depression Scale (HADS) at baseline, 6 and 12 months 7. Self esteem, measured using self-esteem rating scale at baseline, 6 and 12 months	—

Measure

Time frame

1. Symptoms, measured using the Brief Psychiatric Rating Scale (BPRS) at baseline, 6 and 12 months 2. Objective social functioning, measured using the Objective social outcome index (SIX) at baseline, 6 and 12 months 3. Service use, measured using adapted Client Service Receipt Inventory (CSRI) at baseline, 6 and 12 months 4. Therapeutic relationship in community mental health care, measured using STAR-P at baseline, 6 and 12 months 5. Client satisfaction, measured using client satisfaction questionnaire (CSQ-8) at 6 and 12 months 6. Symptoms, measured using Hospital Anxiety and Depression Scale (HADS) at baseline, 6 and 12 months 7. Self esteem, measured using self-esteem rating scale at baseline, 6 and 12 months

—

Countries

Bosnia and Herzegovina

Contacts

Public ContactFrancois van Loggerenberg

f.vanloggerenberg@qmul.ac.uk+44 (0)207 540 4380 Ext: 2339

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026